THY1 and Crouzon syndrome-acanthosis nigricans syndrome: Next, we evaluated whether TSP-2 gene therapy could inhibit TSP-1 mediated TGF-β activation in the rat CAN model as demonstrated before in the anti-Thy1 model (16).